Serotonin 5-HT4 Receptor Agonists
- Name
- Serotonin 5-HT4 Receptor Agonists
- Accession Number
- DBCAT001723
- Description
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT4 RECEPTORS.
- Drugs
Drug Drug Description Naronapride Investigated for use/treatment in gastroesophageal reflux disease (GERD) and gastroparesis. Felcisetrag Felcisetrag (TD-8954) has been used in trials studying the treatment of Enteral Feeding Intolerance and Gastrointestinal Motility Disorder. Renzapride For the treatment of constipation-predominant irritable bowel syndrome (IBS-C). Prucalopride A 5-HT4 receptor agonist indicated to treat adults with chronic idiopathic constipation. - Drugs & Drug Targets
Drug Target Type Naronapride 5-hydroxytryptamine receptor 4 target Renzapride 5-hydroxytryptamine receptor 3A target Renzapride 5-hydroxytryptamine receptor 4 target Prucalopride 5-hydroxytryptamine receptor 4 target Prucalopride Cytochrome P450 3A4 enzyme Prucalopride Serum albumin carrier Prucalopride P-glycoprotein 1 transporter